Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
复制标题
DOI:
10.1177/0272989x16662841
复制
发表时间:
2017-01
期刊:
影响因子:
--
通讯作者:
Ubel PA
中科院分区:
文献类型:
--
作者:
Scherr KA;Fagerlin A;Hofer T;Scherer LD;Holmes-Rovner M;Williamson LD;Kahn VC;Montgomery JS;Greene KL;Zhang B;Ubel PA
To assess the influence of patient preferences and urologist recommendations in treatment decisions for clinically localized prostate cancer. We enrolled 257 men with clinically localized prostate cancer (PSA < 20; Gleason 6 or 7) seen by urologists (primarily residents and fellows) in 4 Veterans Affairs Medical Centers. We measured patients’ baseline preferences prior to their urology appointments, including initial treatment preference, cancer-related anxiety, and interest in sex. In longitudinal follow-up, we determined which treatment patients received. We used hierarchical logistic regression to determine the factors that predicted treatment received (active treatment vs. active surveillance) and urologist recommendations. We also conducted a directed content analysis of recorded clinical encounters to determine if urologists discussed patients’ interest in sex. Patients’ initial treatment preferences did not predict receipt of active treatment versus surveillance (Δχ2 (4) = 3.67, p = .45). Instead, receipt of active treatment was predicted primarily by urologists’ recommendations (Δχ2(2) = 32.81 p < .001). Urologists’ recommendations, in turn, were influenced heavily by medical factors (age and Gleason score) but unrelated to patient preferences (Δχ2 (6) = 0, p = 1). Urologists rarely discussed patients’ interest in sex (< 15% of appointments). Patients’ treatment decisions were based largely upon urologists’ recommendations, which, in turn, were based on medical factors (age and Gleason score) and not on patients’ personal views of the relative pros and cons of treatment alternatives.